Neuroscientific Biopharmaceuticals Ltd (NSB) — Free Cash Flow Generation Index

Latest as of June 2024: 1.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of AU$1.62 Million represents 1% of operating cash flow (AU$1.62 Million). Explore Neuroscientific Biopharmaceuticals Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

AU$1.62 Million

AUD

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Neuroscientific Biopharmaceuticals Ltd Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. For the full cash flow conversion analysis, see NSB operating cash flow.

Annual Free Cash Flow Generation for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year Free Cash Flow Generation Index for Neuroscientific Biopharmaceuticals Ltd. Check NSB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (AUD)	Operating CF	Capital Expenditures	YoY Change
2024	0.96x	AU$42.43K	AU$44.25K	AU$1.81K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).